Weighted Average Number of Shares Outstanding, Basic of Intra-Cellular Therapies, Inc. from 2020 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2020 to Q4 2024.
  • Intra-Cellular Therapies, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2024 was 103M shares, a 7.56% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 103M shares, a 7.56% increase from 2023.
  • Intra-Cellular Therapies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 95.9M shares, a 1.95% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 94M shares, a 15.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Intra-Cellular Therapies, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 103M +7.25M +7.56% 01 Oct 2024 31 Dec 2024 10-K 21 Feb 2025
Q3 2024 106M +9.63M +10% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2024
Q2 2024 104M +7.77M +8.1% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 96.9M +1.74M +1.83% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024
Q4 2023 95.9M +1.84M +1.95% 01 Oct 2023 31 Dec 2023 10-K 21 Feb 2025
Q3 2023 96.1M +1.63M +1.72% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024
Q2 2023 95.9M +1.66M +1.76% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 95.1M +2.53M +2.73% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 94M 01 Oct 2022 31 Dec 2022 10-K 21 Feb 2025
Q3 2022 94.5M +13.2M +16.2% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 94.3M +13.1M +16.1% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 92.6M 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q3 2021 81.4M 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 81.2M 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022

Intra-Cellular Therapies, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 103M +7.25M +7.56% 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025
2023 95.9M +1.84M +1.95% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025
2022 94M +12.8M +15.7% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025
2021 81.3M +10.9M +15.5% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024
2020 70.4M 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.